Market Tracker

04/17 6:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

5.04
Data as of 3:59pm ET
 -0.2199 / -4.18%
Today’s Change
4.39
Today|||52-Week Range
8.19
-16.97%
Year-to-Date

Today’s Trading

Previous close5.26
Today’s open5.19
Day’s range5.01 - 5.34
Volume105,396
Average volume (3 months)54,858
Market cap$196.6M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...+0.43+3.15%
NNVCNanoViricides Inc+0.14+4.23%
RNNRexahn Pharmaceutica...+0.02+2.09%
BOTABiota Pharmaceutical...+0.31+6.01%
Data as of 4:00pm ET, 04/17/2014

Financials

Last reporting dateMarch 14, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts